⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

BAYERCROP - Investment Analysis: Buy Signal or Bull Trap?

← Back to List

⭐ Rating: 3.2

Last Updated Time : 18 Sept 26, 09:16 pm

Key Parameters

⭐ Investment Rating: 3.2

ROE23.7 %
ROCE29.1 %
PEG Ratio43.8
Dividend Yield3.96 %
Debt to equity0.03
PAT Qtr322 Cr.
PAT Prev Qtr162 Cr.
Qtr Profit Var15.4 %
Show all parameters (20 more)
Stock CodeBAYERCROP
Market Cap17,012 Cr.
Current Price3,787 ₹
High / Low5,489 ₹
Stock P/E23.2
Book Value660 ₹
Face Value10.0 ₹
DMA 504,083 ₹
DMA 2004,427 ₹
Chg in FII Hold0.08 %
Chg in DII Hold-0.25 %
RSI21.9
MACD-65.2
Volume91,225
Avg Vol 1Wk33,022
Low price3,761 ₹
High price5,489 ₹
52w Index1.47 %
EPS163 ₹
Industry PE20.5

🏭 Industry

The agricultural sector is currently experiencing strong growth driven by rising global food demand, increasing investment in crop protection technologies, and government initiatives to enhance food security. However, the industry remains cyclical, susceptible to weather events and commodity price fluctuations, necessitating a durable business model with resilient cash flows.

✅ Positive

Bayer’s robust profit growth of 15.4% quarter-over-quarter and a significant increase in PAT to ₹6,892 million demonstrates the strength of its agricultural solutions business and highlights its ability to capitalize on growing global demand for food production. The company's consistently high ROE (23.7%) suggests efficient capital allocation and a durable competitive advantage within the sector.

⚠️ Limitation

Despite strong current profitability, the exceptionally high P/E ratio of 23.2 compared to the industry average of 20.5 indicates that the stock is trading at a premium valuation, which may limit potential upside growth. The substantial PEG ratio of 43.8 further reinforces this elevated valuation, suggesting expectations for future earnings growth are significantly higher than what current market data supports.

📉 Company Negative News

Recent downgrades from MarketsMojo and scanx.trade cite "technical weakness" and "valuation concerns," reflecting investor skepticism regarding the stock's premium valuation and potential risks associated with ongoing market conditions, although the FY26 PAT rise offers some reassurance.

📈 Company Positive News

The announcement of a 21% increase in Bayer CropScience’s FY26 projected Profit alongside approval for Ravi Kirpalani as an independent director suggests continued financial strength and strategic developments supporting investor confidence.

🧾 Long-Term Outlook

An entry zone between 3,600 ₹ and 3,800 ₹ would represent a reasonable valuation given the current metrics, acknowledging the premium but also the underlying profitability. A holding period of 5-7 years is suggested, focusing on consistent dividend income (3.96%) and capitalizing on anticipated long-term growth within the agricultural sector. The company’s durability depends heavily on continued innovation in crop protection and effective management of cyclical industry risks; given the elevated valuation, a trailing stop-loss at the 52 week low of 3761 ₹ offers a prudent exit strategy if downside risk materializes.

Choose Technical Analysis or Fundamental Analysis above to load it.

How BAYERCROP Rates Across All Strategies

★ 3.7
Entry Price: 3,761 ₹.
★ 2.3
Buy Price: 3,761 ₹ (just below current low).
Investment
★ 3.2
You're viewing this analysis below.
★ 2.7
Short-term entry zones would be around 3,761 ₹ (support level) and 4,…
★ 3.7
An entry zone could be established around 3,865 ₹ (low price), recogn…

NIFTY 50 · Investment

NEXT 50 · Investment

MIDCAP · Investment

SMALLCAP · Investment